Get the latest industry news, event updates, and more from Managed healthcare Executive.
FDA Approves Recurrent Respiratory Papillomatosis Treatment, Papzimeos
Read More
Medicare Plans Face Higher Liability From Cap on Out-of-Pocket Drug Costs
Employers Project 10% Rise in Healthcare Costs for 2026
Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says
FDA Approves First Treatment for Chronic Inflammatory Lung Condition
FDA Approves Ajovy for Childhood Migraine Prevention
